Profile
CLRB VRTX REGN VRNA ARGX SGEN
Company Name Cellectar Biosciences, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $10.50M $122.53B $81.42B $72.68B $51.58B $43.15B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 3.26K
CEO James V. Caruso Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren David R. Epstein
Ratings
CLRB VRTX REGN VRNA ARGX SGEN
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
CLRB VRTX REGN VRNA ARGX SGEN
Last Close $2.92 $434.02 $704.31 $106.91 $929.61 $228.74
High 52 $9.7 $513.76 $788 $106.91 $929.61 $228.74
Low 52 $0.24 $366.54 $482.92 $37.86 $532.27 $228.74
Price vs. 52 Week High -69.9 % -15.52 % -10.62 % 0 % 0 % 0 %
Price vs. 52 Week Low 1116.67 % 18.41 % 45.84 % 182.38 % 74.65 % 0 %
Total Return
CLRB VRTX REGN VRNA ARGX SGEN
1 Month Return -35.11 % 4.13 % 21.84 % 0 % 10.19 % 0 %
3 Month Return -37.74 % 11.32 % 22.74 % 1.06 % 40.57 % 0 %
6 Month Return 1091.84 % -1.06 % 18.51 % 49.92 % 64.35 % 0 %
9 Month Return 829.64 % -6.08 % 3.57 % 66.4 % 45.48 % 0 %
YTD Return 876.59 % 7.78 % -1.13 % 130.21 % 51.16 % 0 %
1 Year Return 81.37 % -3.12 % -5.41 % 180.68 % 61.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CLRB VRTX REGN VRNA ARGX SGEN
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -484.42 % 9.76 % 3.92 % -147.93 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
CLRB VRTX REGN VRNA ARGX SGEN
Asset Growth 110.96 % 7.41 % 53.91 % -1.21 %
Gross Profit Growth - 1.16 % - 22.93 %
Revenue Growth - 0.99 % - 24.65 %
Revenue 3 Year - 20.64 % -15.89 % 91.56 %
Revenue 5 Year - 73.64 % - 215.48 %
Revenue 10 Year - 285.02 % - 494.04 %
EBIT Growth -32.9 % 9.09 % -131.37 % -3.48 %
Net Income Growth -4.23 % 2.09 % -224.78 % 9.51 %
Net Income 3 Yeari Growth Per Share 71.98 % 6.32 % -148.34 % -763.59 %
Net Income 5 Yeari Growth Per Share 93.37 % 31.91 % 25.82 % -276.93 %
Net Income 10 Yeari Growth Per Share 99.93 % 680.22 % -35.51 % -624.16 %
Operating Income Growth -32.9 % -7.46 % -133.02 % 10.13 %
Operating Cash Flow Growth (CFG) -46.97 % - -143.33 % 9.07 %
Operating 3 Year CFG 68.04 % -100 % -170.73 % -147.99 %
Operating 5 Year CFG 91.47 % -100 % 54.81 % -195.86 %
Operating 10 Year CFG 99.93 % -100 % 40.15 % -2622.09 %
EPS Growth 65.22 % 5.31 % -214.81 % 10.81 %
EPS Diluted Growth 60.1 % 8.19 % -208.93 % 10.81 %
Book Value Per Share 134.63 % 32.88 % -22.82 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -93.44 % 41.21 % 1.82 % 33.72 %
Share Holder 5 Year Equity Growth Per Share -96.69 % 191.63 % -24.45 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -99.98 % 842.11 % -71.86 % 691.19 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -10.67 % 0.06 % 139.05 % -23.28 %
Free Cash Flow Growth -43.46 % - -144.48 % 3.67 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2022
Profitability
CLRB VRTX REGN VRNA ARGX SGEN
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 79.1 %
Return on Assets TTM -128.87 % 14.78 % 11.11 % -11.01 % 15.06 % -16.61 %
Return on Equity TTM -191.41 % 21.81 % 14.83 % -30.05 % 18.96 % -20.8 %
Return on Capital Employed TTM -309.14 % 19.59 % 10.3 % -8.31 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.35 % 82.61 % 86.12 % 111.64 % 237.3 % 101.33 %
EBT Per Ebit TTM 62.55 % 111.4 % 146.19 % 130.36 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -6873.25 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.91
Payables Turnover TTM 0.01 0.4 2.1 2.37 0.9 1.97
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 0.96
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -9.39 14.55 48.39 -0.85 5.67 -2.46
Free Cash Flow Per Share TTM -9.41 13.06 39.66 -0.85 5.58 -2.88
Cash Per Share TTM 397.03 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.21 % 89.76 % 81.96 % 100.75 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -6873.25 % 202.64 % 184 % -29.66 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.35 36.72 19.95 -995.27 129.37 -81.26
Price To Operating Cash Flows Ratio TTM -0.35 32.86 16.2 -126.33 146.05 -93.1
Price Cash Flow Ratio TTM -0.35 32.86 16.2 -126.33 146.05 -93.1
Income Statement (TTM)
CLRB VRTX REGN VRNA ARGX SGEN
Revenue $0B $12.07B $14.34B $0.03B $2.19B $1.96B
Gross Profit $0B $10.27B $12.24B $0.03B $1.96B $1.55B
Gross Profit Ratio 0% 85.03% 85.35% 93.89% 89.62% 79.1%
EBITDA $-0.05B $4.97B $5.82B $-0.12B $0.11B $-0.62B
Net Income $-0.04B $3.95B $4.5B $-0.14B $0.83B $-0.61B
EPS Diluted -41.89 15.32 41.48 -1.73 12.78 -3.3
Balance Sheet (MRQ)
CLRB VRTX REGN VRNA ARGX SGEN
Long Term Debt $0B $3.8B $2.71B $0.12B $0.03B $0.04B
Total Liabilities $0.01B $7.48B $9.3B $0.27B $0.7B $0.87B
Total Equity $0.01B $18.67B $31.26B $0.2B $5.5B $2.8B
Total Investments $0B $7.33B $15.75B $0.02B $1.93B $1.42B
Total Debt $0B $3.88B $2.71B $0.12B $0.04B $0.04B
Total Assets $0.03B $26.14B $40.56B $0.47B $6.2B $3.67B
Cash Flow Statement (TTM)
CLRB VRTX REGN VRNA ARGX SGEN
Net Income $-0.04B $3.95B $4.5B $-0.17B $0.83B $-0.61B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $-0.23B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.05B $3.63B $4.98B $-0.12B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to CLRB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00001 336.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
VXF Vanguard Extended Market Index Fund 0.00012 216.28
IWC iShares Micro-Cap ETF 0.00238 166.03
VUN.TO Vanguard U.S. Total Market Index ETF 0.00001 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00001 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.38
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.36
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00001 52.22
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00001 52.21
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.21
VGRO.TO Vanguard Growth ETF Portfolio 0 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
DFAS Dimensional U.S. Small Cap ETF 0.00011749 75.67
VTSAX Vanguard Total Stock Market Index Fund 0.00001 163.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00012 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00001 163.92
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00012 164.02
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 475.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00012 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 307.49
Unlock